FdaApplication
NDA 019395
Identifiers
- fda_app_no: NDA019395
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS MEDICAL CARE NORTH AMERICA |
| application_type | NDA |
| approval_date | 1986-03-26 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER | CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE | 25.7MG/100ML;1.5GM/100ML;538MG/100ML;448MG/100ML | SOLUTION;INTRAPERITONEAL |
| INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER | CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE | 25.7MG/100ML;2.5GM/100ML;538MG/100ML;448MG/100ML | SOLUTION;INTRAPERITONEAL |
| INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER | CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE | 25.7MG/100ML;4.25GM/100ML;538MG/100ML;448MG/100ML | SOLUTION;INTRAPERITONEAL |
3 products